Tune-in today, June 12th at 2:40 p.m. ET corporate update from Corbus CEO, Yuval Cohen, Ph.D., at the 45th Annual Goldman Sachs Global Healthcare Conference: https://bit.ly/3R5a1MG
Corbus Pharmaceuticals’ Post
More Relevant Posts
-
Talent Expert | Executive Search | Sales & Marketing | Diagnostic, Dental, Med Device, Technology & Software
In this month's blog, I explore the top themes and trends from this year's JP Morgan Healthcare Conference. If you missed it, you can catch up on the highlights here: https://lnkd.in/e7WgcZa5. Did you attend? Let us know your thoughts and takeaways in the comments below! Lee Kester Molly White Jones Kester Search Group, LLC ® #JPmorganhealthcare #healthcaretrends
To view or add a comment, sign in
-
I’m thrilled to be on a panel at the upcoming Nashville Healthcare Sessions conference! I’ll be joining industry leaders Adam Boehler from Rubicon Founders and Anna Haghgooie from Valtruis. Together, we’ll explore the evolution of healthcare investing and the current landscape after a tumultuous five years. What can you expect? 🤔 🔍 Insights into market maturation and what we’re observing in today’s investment strategies. 💡 Discussion on how these dynamics are influencing capital strategies for companies moving forward. 📈 An overview of the changes operators are making to secure the best deals. 🔮 A look at investor trends for the remainder of the year and what’s on the horizon for 2025. This is a fantastic opportunity to gain valuable insights and network with fellow healthcare enthusiasts and professionals. Don’t miss out on what promises to be a thought-provoking and informative session! #NashvilleHealthcareSessions #HealthcareInvestment #PanelDiscussion #Networking #HealthcareInnovation #InvestSmart #2025Trends
To view or add a comment, sign in
-
Amount B in life sciences and healthcare: an industry perspective Richard Schmidtke, Heike Schenkelberg, and David Sauer of Deloitte Germany analyse the impact of specific characteristics of the life sciences and healthcare industry on the applicability of amount B http://spr.ly/6047mbpWt
To view or add a comment, sign in
-
Amount B in life sciences and healthcare: an industry perspective Richard Schmidtke, Heike Schenkelberg, and David Sauer of Deloitte Germany analyse the impact of specific characteristics of the life sciences and healthcare industry on the applicability of amount B http://spr.ly/6048mb5bY
To view or add a comment, sign in
-
To everyone attending or following #JPM2024, here's what to expect based on top themes we are seeing.
The 42nd annual J.P. Morgan Healthcare Conference is underway, and the Syneos Health Corporate Affairs Practice has a few predictions about the stories that will dominate media coverage at this year’s event. Click through to see the five themes that emerged from conversations with newsmakers, dealmakers, CEOs, VCs, scientists, and influential reporters leading up to #JPM2024. We are closely following the action live at #JPM2024 and will share more media insights coming out of the conference. Stay tuned for more conference coverage from our team.
To view or add a comment, sign in
-
J.P. Morgan Healthcare Conference has just started, and these are the exciting and very relevant topics that will likely be discussed and elaborated, as predicted by the Syneos Health Corporate Affairs Practice. #syneoshealth #healthcare
The 42nd annual J.P. Morgan Healthcare Conference is underway, and the Syneos Health Corporate Affairs Practice has a few predictions about the stories that will dominate media coverage at this year’s event. Click through to see the five themes that emerged from conversations with newsmakers, dealmakers, CEOs, VCs, scientists, and influential reporters leading up to #JPM2024. We are closely following the action live at #JPM2024 and will share more media insights coming out of the conference. Stay tuned for more conference coverage from our team.
To view or add a comment, sign in
-
"Exciting insights from Dr. James Mault on the future of healthcare! Discover how M42 Health 's cutting-edge technology is revolutionizing the industry. Check out the full discussion here: https://bit.ly/3XliEqf 🚀 #HealthTech #Innovation"
Step into the future of health with Dr. James Mault, Chief Executive Officer of BiolntelliSense and M42 Advisory Board member, as he underscores the profound impact of M42’s tech-driven disruption. Discover how innovative solutions are reshaping the healthcare ecosystem and establishing new clinical frontiers. Watch the full discussion on our YouTube channel - https://bit.ly/3XliEqf
To view or add a comment, sign in
-
With the election year approaching, our thought leaders are discussing what critical topics they would like to see addressed in healthcare throughout 2024. Market Access Strategy SVP, Raymond Johnson, highlights the importance of helping clients navigate the potential business impacts of the Inflation Reduction Act in this Med Ad News feature article. Read here: 🔗 https://bit.ly/3txL9EI
To view or add a comment, sign in
-
The second panel discussion at the 2024 Richmond Healthcare Forum was focused on growth considerations and private equity versus independent. Read our overview of the key takeaways on our blog. https://hubs.ly/Q02wQrNV0
2024 Healthcare Forum: Growth Considerations | Richmond CPAs
To view or add a comment, sign in
-
Step into the future of health with Dr. James Mault, Chief Executive Officer of BiolntelliSense and M42 Advisory Board member, as he underscores the profound impact of M42’s tech-driven disruption. Discover how innovative solutions are reshaping the healthcare ecosystem and establishing new clinical frontiers. Watch the full discussion on our YouTube channel - https://bit.ly/3XliEqf
To view or add a comment, sign in
14,598 followers